Matternet Partners with Swisslog Healthcare's TransLogic to Bring Drone Delivery to Thousands of North American Hospitals
The companies will also explore expanding the partnership to installation, support, and maintenance services.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Matternet (MTTN) has partnered with Swisslog Healthcare’s TransLogic to distribute drone delivery systems to hospitals through TransLogic’s sales team.
The agreement gives Matternet’s M3 systems a distribution channel into TransLogic’s established customer base of 3,000+ hospitals globally, including more than 2,300 in North America. During the partnership’s first year, the companies plan to bring drone delivery to hospital systems in California, Florida, and Arizona. The planned network would connect hospitals, laboratories, pharmacies, and clinics by air, complementing Swisslog’s transport systems inside hospital buildings.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate point. Forward-looking: it has not happened yet and may not happen.TransLogic’s sales team will distribute M3 systems into its customer base of 3,000+ hospitals globally.
- Minor point. Forward-looking: it has not happened yet and may not happen.First-year deployment plans target hospital systems in California, Florida, and Arizona.
- Minor point. Forward-looking: it has not happened yet and may not happen.Potential service expansion will be explored, covering installation, support, and maintenance.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Swisslog Healthcare’s automated transport systems operate in more than 2,300 hospitals in North America, including 18 of the top 20 U.S. hospitals
- Network will deliver medication, laboratory specimens, and urgent supplies between hospital facilities
- First U.S. deployments target California, Florida, and Arizona
MOUNTAIN VIEW, Calif and WESTMINSTER, Colo., Oct. 29, 2026 (GLOBE NEWSWIRE) -- TransLogic, a Swisslog Healthcare company and a leading supplier in transport automation for hospitals, and Matternet, Inc. (OTCQB: MTTN), a leading developer of autonomous drone networks for ultra-fast, low-cost, and zero-emissions delivery, have partnered to close the last-mile gap in hospital logistics. For the first time, healthcare systems will gain access to a single automated transportation network that extends from the pneumatic tube station inside a hospital to the satellite facilities outside it, replacing fragmented manual deliveries.
A New Standard for Hospital Logistics
Until now, hospitals have managed the movement of medications, laboratory specimens, and critical supplies in two disconnected ways. Swisslog Healthcare automates delivery inside hospital buildings through pneumatic tube systems, pharmacy automation, and specimen tracking. Matternet automates the same movement between facilities by air.
"For years, hospitals have automated what happens inside their walls. This partnership extends that automation to everything outside them," said Cory Kwarta, CEO of Swisslog Healthcare. "Connecting our network with Matternet's aerial delivery platform is a meaningful step forward for hospitals and the patients they serve."
Partnership Details
During the first year of the partnership, the two companies will work together to bring drone delivery to hospital systems in California, Florida, and Arizona. The collaboration centers on Matternet's next-generation M3 drone delivery platform, which carries packages up to 11 pounds within a 10-mile service radius and operates fully autonomously. Between flights, the M3 Aircraft is stored and charged in the compact M3 Dock, which can be installed on a hospital rooftop or other underutilized space. Deployed across a health system, Matternet’s M3 drone delivery system complements Swisslog’s tube network, connecting hospitals, labs, pharmacies, and clinics into a single on-demand delivery network. Matternet has operated drone delivery for health systems since 2017 in Europe and 2019 in the U.S., transporting lab samples, vaccines, pathology specimens, specialty pharmaceuticals, and a continuously expanding set of payload types.
As part of the agreement, the TransLogic sales team will serve as a distribution channel for M3 systems into TransLogic's established customer base of 3,000+ hospitals globally, including more than 2,300 in North America. Every day, major hospitals need to move hundreds of small packages—like medications, laboratory specimens, and supplies—urgently between facilities, often relying on ground couriers that can be costly and slow. With this partnership, Matternet's goal is to help make drone delivery available to every hospital across the country, moving items across healthcare campuses and beyond. The two companies will also explore expanding the partnership to include installation, support, and maintenance services, with Swisslog Healthcare's field service organization performing installation work for Matternet infrastructure at hospital sites.
Expanding the Reach of Drone Delivery
"Swisslog Healthcare has been a leader in automated hospital transport for decades. This partnership gives us the ability to bring the benefits of drone delivery directly into the more than 3,000 hospitals worldwide that depend on Swisslog tube systems," said Andreas Raptopoulos, Founder and CEO of Matternet. "A lab specimen may be shipped from a remote clinic to a central lab by a drone and then travel by pneumatic tube inside a hospital to its destination. End-to-end automation will define the future of hospital logistics."
About TransLogic
TransLogic, a Swisslog Healthcare company, builds on its 100 years of operational technology expertise to reliably automate the delivery of critical items and leverage innovations which transcend industry standards in transport automation. TransLogic products are manufactured in the USA, resulting in nominal supply chain issues, fewer shipping delays, and quality controls which meet North America’s standards. Learn more about TransLogic solutions at translogic.com.
About Swisslog Healthcare
Swisslog Healthcare provides pharmacy workflow automations through robotic solutions and operational technology that enable hospitals and health systems to assist providers in treating patients across the continuum of care. Integrating transport and pharmacy automation, value-added services, and intelligent software, Swisslog Healthcare enables healthcare providers to respond to patients' needs quickly and with greater accuracy. The company minimizes many sources of operational waste, so providers achieve higher levels of productivity to impact the well-being of patients in positive ways. For more information, visit www.swisslog-healthcare.com.
About Matternet
Matternet is a leading developer of commercial drone delivery systems for urban and suburban environments. Its M2 platform is the only drone delivery system to achieve standard Type Certification and Production Certification from the U.S. Federal Aviation Administration, and M3 is its next-generation platform designed for end-to-end autonomous aerial delivery at scale. Matternet’s technology also includes automated ground infrastructure and the Matternet Software Platform, and is operated directly for customers or in partnership with logistics organizations, such as UPS.
Matternet has achieved many industry firsts, including being the first company authorized for commercial Beyond Visual Line of Sight (BVLOS) drone delivery operations over cities in Switzerland and, with UPS Flight Forward, the first to launch routine revenue-generating drone delivery operations in the U.S. Matternet has more than a decade of operating experience, beginning with humanitarian drone delivery missions in 2014, launching B2B healthcare operations in Europe in 2017 and the U.S. in 2019, and expanding into B2C drone delivery operations in Silicon Valley in 2024.
Additional information about Matternet, including SEC filings and investor materials, is available at investor.matternet.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections based on management’s beliefs and assumptions and on information currently available to management and are subject to risks and uncertainties that could cause results to be materially different from expectations. Forward-looking statements relate to, among other things, the Company’s intent to scale its drone delivery system, expand commercial availability across restaurant, retail, healthcare and industrial logistics markets, advance and commercialize its next-generation autonomous delivery platform, the targeted specifications and installation requirements of M3, the expected performance and timing of M3 testing, customer pilots and commercial service, the regulatory approvals required for M3, its plans to scale manufacturing capacity, and its customer and strategic partnerships, as well as other plans, objectives, expectations, business strategy, growth opportunities, market opportunity, commercial expansion, regulatory developments, financing plans, and future operating performance.
Important factors that could cause actual results to differ materially from those expressed or implied include, among others, risks related to the Company’s ability to complete the development, testing and certification of M3, achieve M3’s targeted specifications and performance, scale commercial operations, obtain and maintain regulatory approvals, including site and local approvals for its ground infrastructure, manufacture and deploy its technology at scale, secure customer contracts and partnerships, access capital on acceptable terms to fund its operations and M3 development, compete effectively, and execute its business plan, as well as other factors detailed from time to time in the reports the Company files with the SEC, including the risk factors in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. Copies of reports filed with the SEC are posted on the Company’s website and are available without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, the Company disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.
Media Contacts:
TransLogic
Sofia Ashley
10 to 1 Public Relations
sofia@10to1pr.com
(480) 468-3349
Sadie Peltz
10 to 1 Public Relations
sadie@10to1pr.com
(480) 524-9899
Matternet
Media: press@matternet.com
Business: business@matternet.com
Investors: investors@matternet.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.